To include your compound in the COVID-19 Resource Center, submit it here.

Nasulin intranasal insulin: Preliminary Phase IIa data

Preliminary data from a double-blind, U.S. Phase IIa trial in 94 patients showed that inhaled Nasulin in combination with basal insulin and oral diabetes agents missed

Read the full 264 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE